Novel thromboxane A 2 analog-induced IUGR mouse model

Journal of Developmental Origins of Health and Disease

Volumn 2, Issue 5, 2011, Pages 291-301

  Fung, C ^a   Brown, A ^a   Cox, J ^a   Callaway, C ^a   McKnight, R ^a   Lane, R ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Key wordsintrauterine growth restriction; mouse model; thromboxane A 2 analog; U 46619; uteroplacental insufficiency

Indexed keywords

EID: 84867355173     PISSN: 20401744     EISSN: 20401752     Source Type: Journal    
DOI: 10.1017/S2040174411000535     Document Type: Article

References (59)

1. Schroder HJ. Models of fetal growth restriction. Eur J Obstet Gynecol Reprod Biol. 2003; 110(Suppl. 1), S29-S39. (Pubitemid 37072138)
2. Battaglia FC, Lubchenco LO. A practical classification of newborn infants by weight and gestational age. J Pediatr. 1967; 71, 159-163.
3. Barker DJ. The origins of the developmental origins theory. J Intern Med. 2007; 261, 412-417. (Pubitemid 46587729)
4. Vuguin PM. Animal models for small for gestational age and fetal programming of adult disease. Horm Res. 2007; 68, 113-123. (Pubitemid 47254525)
5. Wigglesworth JS. Experimental growth retardation in the foetal rat. J Pathol Bacteriol. 1964; 88, 1-13.
6. Ogata ES, Bussey ME, LaBarbera A, Finley S. Altered growth, hypoglycemia, hypoalaninemia, and ketonemia in the young rat: postnatal consequences of intrauterine growth retardation. Pediatr Res. 1985; 19, 32-37. (Pubitemid 15187468)
7. Lane RH, Flozak AS, Ogata ES, Bell GI, Simmons RA. Altered hepatic gene expression of enzymes involved in energy metabolism in the growth-retarded fetal rat. Pediatr Res. 1996; 39, 390-394. (Pubitemid 26070829)
8. Lane RH, Ramirez RJ, Tsirka AE, et al. Uteroplacental insufficiency lowers the threshold towards hypoxia-induced cerebral apoptosis in growth-retarded fetal rats. Brain Res. 2001; 895, 186-193. (Pubitemid 32231155)
9. McAdam BF, Byrne D, Morrow JD, Oates JA. Contribution of cyclooxygenase-2 to elevated biosynthesis of thromboxane A2 and prostacyclin in cigarette smokers. Circulation. 2005; 112, 1024-1029. (Pubitemid 41170271)
10. Goodwill AG, James ME, Frisbee JC. Increased vascular thromboxane generation impairs dilation of skeletal muscle arterioles of obese Zucker rats with reduced oxygen tension. Am J Physiol Heart Circ Physiol. 2008; 295, H1522-H1528.
11. Tanbe AF, Khalil RA. Circulating and vascular bioactive factors during hypertension in pregnancy. Curr Bioact Compd. 2010; 6, 60-75.
12. Rocca B, Loeb AL, Strauss JF III, et al. Directed vascular expression of the thromboxane A2 receptor results in intrauterine growth retardation. Nat Med. 2000; 6, 219-221. (Pubitemid 30082370)
13. Hayakawa M, Takemoto K, Nakayama A, et al. An animal model of intrauterine growth retardation induced by synthetic thromboxane a(2). J Soc Gynecol Investig. 2006; 13, 566-572. (Pubitemid 44914124)
14. Ogata ES, Bussey ME, Finley S. Altered gas exchange, limited glucose and branched chain amino acids, and hypoinsulinism retard fetal growth in the rat. Metabolism. 1986; 35, 970-977. (Pubitemid 17184368)
15. Gentili S, Morrison JL, McMillen IC. Intrauterine growth restriction and differential patterns of hepatic growth and expression of IGF1, PCK2, and HSDL1 mRNA in the sheep fetus in late gestation. Biol Reprod. 2009; 80, 1121-1127.
16. Randhawa RS. The insulin-like growth factor system and fetal growth restriction. Pediatr Endocrinol Rev. 2008; 6, 235-240.
17. Lane RH, MacLennan NK, Hsu JL, Janke SM, Pham TD. Increased hepatic peroxisome proliferator-activated receptorgamma coactivator-1 gene expression in a rat model of intrauterine growth retardation and subsequent insulin resistance. Endocrinology. 2002; 143, 2486-2490. (Pubitemid 34701309)
18. Adamo ML, Neuenschwander S, LeRoith D, Roberts CT Jr. Structure, expression, and regulation of the IGF-I gene. Adv Exp Med Biol. 1993; 343, 1-11. (Pubitemid 24059271)
19. Beale EG, Hammer RE, Antoine B, Forest C. Disregulated glyceroneogenesis: PCK1 as a candidate diabetes and obesity gene. Trends Endocrinol Metab. 2004; 15, 129-135. (Pubitemid 38445067)
20. Meirhaeghe A, Crowley V, Lenaghan C, et al. Characterization of the human, mouse and rat PGC1 beta (peroxisomeproliferator-activated receptor-gamma co-activator 1 beta) gene in vitro and in vivo. Biochem J. 2003; 373, 155-165. (Pubitemid 36819511)
21. Krege JH, Hodgin JB, Hagaman JR, Smithies O. A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension. 1995; 25, 1111-1115.
22. Roberts LJ II, Sweetman BJ, Oates JA. Metabolism of thromboxane B2 in man. Identification of twenty urinary metabolites. J Biol Chem. 1981; 256, 8384-8393. (Pubitemid 12254787)
23. Pradelles P, Grassi J, Maclouf J. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal Chem. 1985; 57, 1170-1173.
24. A J, Trygg J, Gullberg J, et al. Extraction and GC/MS analysis of the human blood plasma metabolome. Anal Chem. 2005; 77, 8086-8094. (Pubitemid 43000566)
25. MacLennan NK, James SJ, Melnyk S, et al. Uteroplacental insufficiency alters DNA methylation, one-carbon metabolism, and histone acetylation in IUGR rats. Physiol Genomics. 2004; 18, 43-50. (Pubitemid 39319485)
26. Pham TD, MacLennan NK, Chiu CT, et al. Uteroplacental insufficiency increases apoptosis and alters p53 gene methylation in the full-term IUGR rat kidney. Am J Physiol Regul Integr Comp Physiol. 2003; 285, R962-R970. (Pubitemid 37296346)
27. van Nas A, Guhathakurta D, Wang SS, et al. Elucidating the role of gonadal hormones in sexually dimorphic gene coexpression networks. Endocrinology. 2009; 150, 1235-1249.
28. Smirnov AN. Hormonal mechanisms of sex differentiation of the liver: the modern concepts and problems. Ontogenez. 2009; 40, 334-354.
29. Joss-Moore LA, Wang Y, Campbell MS, et al. Uteroplacental insufficiency increases visceral adiposity and visceral adipose PPARgamma2 expression in male rat offspring prior to the onset of obesity. Early Hum Dev. 2010; 86, 179-185.
30. Baserga M, Hale MA, Wang ZM, et al. Uteroplacental insufficiency alters nephrogenesis and downregulates cyclooxygenase-2 expression in a model of IUGR with adultonset hypertension. Am J Physiol Regul Integr Comp Physiol. 2007; 292, R1943-R1955. (Pubitemid 46708550)
31. Eskenazi B, Fenster L, Sidney S, Elkin EP. Fetal growth retardation in infants of multiparous and nulliparous women with preeclampsia. Am J Obstet Gynecol. 1993; 169, 1112-1118. (Pubitemid 24001623)
32. Pietrantoni M, O'Brien WF. The current impact of the hypertensive disorders of pregnancy. Clin Exp Hypertens. 1994; 16, 479-492. (Pubitemid 24225604)
33. Duncan JR, Cock ML, Loeliger M, et al. Effects of exposure to chronic placental insufficiency on the postnatal brain and retina in sheep. J Neuropathol Exp Neurol. 2004; 63, 1131-1143. (Pubitemid 39492019)
34. Li RY, Tsutsui Y. Growth retardation and microcephaly induced in mice by placental infection with murine cytomegalovirus. Teratology. 2000; 62, 79-85. (Pubitemid 30614361)
35. von Versen-Hoeynck FM, Powers RW. Maternal-fetal metabolism in normal pregnancy and preeclampsia. Front Biosci. 2007; 12, 2457-2470.
36. Evans RW, Powers RW, Ness RB, et al. Maternal and fetal amino acid concentrations and fetal outcomes during pre-eclampsia. Reproduction. 2003; 125, 785-790. (Pubitemid 36722546)
37. Barry JS, Rozance PJ, Anthony RV. An animal model of placental insufficiency-induced intrauterine growth restriction. Semin Perinatol. 2008; 32, 225-230. (Pubitemid 351636318)
38. Foley TP Jr, DePhilip R, Perricelli A, Miller A. Low somatomedin activity in cord serum from infants with intrauterine growth retardation. J Pediatr. 1980; 96, 605-610. (Pubitemid 10147573)
39. Unterman TG, Simmons RA, Glick RP, Ogata ES. Circulating levels of insulin, insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding proteins in the small for gestational age fetal rat. Endocrinology. 1993; 132, 327-336. (Pubitemid 23019521)
40. Baker J, Liu JP, Robertson EJ, Efstratiadis A. Role of insulinlike growth factors in embryonic and postnatal growth. Cell. 1993; 75, 73-82. (Pubitemid 23306022)
41. Fu Q, Yu X, Callaway CW, Lane RH, McKnight RA. Epigenetics: intrauterine growth retardation (IUGR) modifies the histone code along the rat hepatic IGF-1 gene. FASEB J. 2009; 23, 2438-2449.
42. Varvarigou AA. Intrauterine growth restriction as a potential risk factor for disease onset in adulthood. J Pediatr Endocrinol Metab. 2010; 23, 215-224.
43. Veening MA, Van Weissenbruch MM, Delemarre-Van De Waal HA. Glucose tolerance, insulin sensitivity, and insulin secretion in children born small for gestational age. J Clin Endocrinol Metab. 2002; 87, 4657-4661. (Pubitemid 35247057)
44. Barker DJ, Eriksson JG, Forsen T, Osmond C. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol. 2002; 31, 1235-1239. (Pubitemid 36204489)
45. Hensen K, Braem C, Declercq J, et al. Targeted disruption of the murine Plag1 proto-oncogene causes growth retardation and reduced fertility. Dev Growth Differ. 2004; 46, 459-470. (Pubitemid 39546093)
46. Tamemoto H, Kadowaki T, Tobe K, et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature. 1994; 372, 182-186. (Pubitemid 24347838)
47. Vuguin PM, Kedees MH, Cui L, et al. Ablation of the glucagon receptor gene increases fetal lethality and produces alterations in islet development and maturation. Endocrinology. 2006; 147, 3995-4006. (Pubitemid 44268351)
48. Collins LL, Lee YF, Heinlein CA, et al. Growth retardation and abnormal maternal behavior in mice lacking testicular orphan nuclear receptor 4. Proc Natl Acad Sci USA. 2004; 101, 15058-15063. (Pubitemid 39391718)
49. Hansen TV, Hammer NA, Nielsen J, et al. Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice. Mol Cell Biol. 2004; 24, 4448-4464. (Pubitemid 41071014)
50. Crossey PA, Pillai CC, Miell JP. Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice. J Clin Invest. 2002; 110, 411-418. (Pubitemid 34847974)
51. Li M, Yee D, Magnuson TR, Smithies O, Caron KM. Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice. J Clin Invest. 2006; 116, 2653-2662. (Pubitemid 44511629)
52. Ivanova M, Dobrzycka KM, Jiang S, et al. Scaffold attachment factor B1 functions in development, growth, and reproduction. Mol Cell Biol. 2005; 25, 2995-3006. (Pubitemid 40464304)
53. Yoshida T, Gan Q, Franke AS, et al. Smooth and cardiac muscleselective knockout of Kruppel-like factor 4 causes postnatal death and growth retardation. J Biol Chem. 2010; 285, 21175-21184.
54. Esposito ER, Horn KH, Greene RM, Pisano MM. An animal model of cigarette smoke-induced in utero growth retardation. Toxicology. 2008; 246, 193-202.
55. Gandley RE, Jeyabalan A, Desai K, et al. Cigarette exposure induces changes in maternal vascular function in a pregnant mouse model. Am J Physiol Regul Integr Comp Physiol. 2010; 298, R1249-R1256.
56. Kaminen-Ahola N, Ahola A, Maga M, et al. Maternal ethanol consumption alters the epigenotype and the phenotype of offspring in a mouse model. PLoS Genet. 2010; 6, e1000811.
57. Coe BL, Kirkpatrick JR, Taylor JA, vom Saal FS. A new 'crowded uterine horn' mouse model for examining the relationship between foetal growth and adult obesity. Basic Clin Pharmacol Toxicol. 2008; 102, 162-167. (Pubitemid 351143440)
58. Sutton GM, Centanni AV, Butler AA. Protein malnutrition during pregnancy in C57BL/6J mice results in offspring with altered circadian physiology before obesity. Endocrinology. 2010; 151, 1570-1580.
59. Bobetsis YA, Barros SP, Lin DM, Arce RM, Offenbacher S. Altered gene expression in murine placentas in an infectioninduced intrauterine growth restriction model: a microarray analysis. J Reprod Immunol. 2010; 85, 140-148.